Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2015 Apr 8;24(6):962–968. doi: 10.1158/1055-9965.EPI-14-1429

Table 2.

Multivariable* Relative Risks of Postmenopausal Breast Cancer by AR Status According to Body Mass Index and Weight Change in the Nurses’ Health Study (1980–2006).

Overall invasive
breast cancer
(n=5,953)
NOT accounting for ER/PR status Accounting for ER/PR status


AR+ (n=1,701) AR− (n=497) P-het AR+ (n=1,701) AR− (n=497) P-het
BMI (kg/m2)
  <23 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
  23–<25 1.09 (1.01, 1.18) 0.96 (0.83, 1.10) 1.34 (1.03,1.75) 0.98 (0.85, 1.14) 1.39 (1.02,1.88)
  25–<27.5 1.18 (1.09, 1.27) 1.10 (0.95, 1.26) 1.20 (0.91,1.58) 1.09 (0.95, 1.26) 1.29 (0.95,1.75)
  27.5–<30 1.34 (1.23, 1.46) 1.15 (0.98, 1.35) 1.68 (1.26,2.26) 1.13 (0.96, 1.33) 1.55 (1.11,2.17)
   ≥ 30 1.47 (1.35, 1.59) 1.20 (1.03, 1.40) 1.54 (1.15, 2.06) 0.14 1.17 (1.00, 1.37) 1.64 (1.21,2.24) 0.05
p-trend <0.0001 0.003 0.01 0.12 0.09
Per 5 kg/m2increment 1.16 (1.13,1.20) 1.09 (1.03,1.15) 1.14 (1.03,1.27) 0.47 1.07 (1.01, 1.13) 1.16 (1.05, 1.29) 0.17

Weight change since age 18 y, kg
Loss
  ≥ 5.0 0.80 (0.66, 0.97) 0.98 (0.70, 1.36) 1.40 (0.74, 2.64) 0.96 (0.68, 1.34) 0.99 (0.47, 2.09)
  2.0–<5 1.05 (0.87, 1.26) 0.95 (0.68, 1.34) 1.88 (1.04, 3.38) 0.87 (0.60, 1.25) 1.59 (0.81, 3.11)
Loss or gain <2.0 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Gain
  2.0–<10 1.19 (1.05, 1.34) 1.10 (0.89, 1.35) 1.50 (0.97, 2.33) 1.10 (0.89, 1.38) 1.29 (0.79, 2.11)
  10–<20 1.23 (1.10, 1.39) 1.14 (0.93, 1.41) 1.57 (1.01, 2.42) 1.12 (0.90, 1.40) 1.44 (0.89, 2.33)
  ≥ 20 1.48 (1.31, 1.66) 1.24 (1.00, 1.54) 1.76 (1.12, 2.75) 0.17 1.23 (0.98, 1.53) 1.59 (0.98, 2.60) 0.34
Per 5 kg change 1.06 (1.05, 1.08) 1.04 (1.02,1.06) 1.04 (1.00,1.08) >0.99 1.04 (1.01,1.06) 1.05 (1.01,1.10) 0.52
*

MV-Adjusted for age at menarche, body mass index at age 18 years, height, parity and age at first birth, alcohol intake, postmenopausal hormone use, age at menopause, family history of breast cancer, and history of benign breast disease. There were 5,191 overall invasive breast tumors, 1,520 AR+, and 446 AR− tumors for weight change analyses.

p-values for heterogeneity between AR+ and AR− tumors.